CATALOGO DEI PRODOTTI DELLA RICERCA

BUSTI, Fabiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.789
EU - Europa 3.635
AS - Asia 2.612
SA - Sud America 441
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 97
OC - Oceania 8
Totale 11.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.590
RU - Federazione Russa 1.499
SG - Singapore 951
CN - Cina 733
GB - Regno Unito 604
IT - Italia 398
BR - Brasile 340
VN - Vietnam 260
HK - Hong Kong 234
SE - Svezia 227
DE - Germania 197
FR - Francia 175
IE - Irlanda 162
FI - Finlandia 138
KR - Corea 96
CA - Canada 91
BD - Bangladesh 87
JP - Giappone 47
IN - India 42
NL - Olanda 40
UA - Ucraina 38
AR - Argentina 34
ID - Indonesia 29
BE - Belgio 27
ES - Italia 27
ZA - Sudafrica 23
IQ - Iraq 21
MX - Messico 21
TR - Turchia 21
PK - Pakistan 18
EC - Ecuador 16
NG - Nigeria 16
PL - Polonia 16
CR - Costa Rica 14
AT - Austria 11
CL - Cile 11
GT - Guatemala 11
HN - Honduras 11
LT - Lituania 11
VE - Venezuela 11
EG - Egitto 10
IR - Iran 10
SV - El Salvador 10
TG - Togo 10
CW - ???statistics.table.value.countryCode.CW??? 9
JM - Giamaica 9
TT - Trinidad e Tobago 9
AU - Australia 8
BJ - Benin 8
CO - Colombia 8
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
BO - Bolivia 7
NI - Nicaragua 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
GR - Grecia 6
JO - Giordania 6
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
KE - Kenya 5
RO - Romania 5
SA - Arabia Saudita 5
AL - Albania 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GP - Guadalupe 4
HR - Croazia 4
KG - Kirghizistan 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
PY - Paraguay 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
CY - Cipro 3
EU - Europa 3
LB - Libano 3
PH - Filippine 3
PR - Porto Rico 3
PT - Portogallo 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
BZ - Belize 2
CI - Costa d'Avorio 2
ET - Etiopia 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
MY - Malesia 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
Totale 11.577
Salva come PNG Salva come JPEG
Città #
Ashburn 710
Moscow 505
Singapore 497
Southend 463
San Jose 451
Chandler 416
Dallas 328
Jacksonville 227
Hong Kong 224
Ann Arbor 164
Dublin 160
Council Bluffs 145
Beijing 143
New York 141
Verona 137
Woodbridge 130
The Dalles 104
Los Angeles 87
Ho Chi Minh City 86
Houston 69
Wilmington 66
Lawrence 60
Santa Clara 60
Princeton 59
Munich 52
Helsinki 48
Jinan 43
Boardman 42
Nanjing 40
Tokyo 40
São Paulo 38
Hanoi 37
Buffalo 36
Redondo Beach 34
Milan 27
Shenyang 27
Montreal 26
Brussels 25
London 25
Orem 24
Brooklyn 23
Rome 21
Turku 21
Lancaster 20
Redmond 20
Falkenstein 19
Tianjin 19
Toronto 19
Haikou 18
Phoenix 18
Seoul 18
Sindelfingen 18
Zhengzhou 18
Columbus 17
Hebei 17
San Francisco 17
Seattle 17
Falls Church 16
Nanchang 16
Ningbo 16
Atlanta 15
Chennai 15
Chicago 15
Denver 15
Poplar 15
Frankfurt am Main 14
Abuja 13
Bologna 13
Changsha 13
Warsaw 13
Amsterdam 12
Charlotte 12
Dhaka 12
Guangzhou 12
Haiphong 12
Jakarta 12
Lappeenranta 12
Nuremberg 12
San José 12
Johannesburg 11
Rio de Janeiro 11
Taiyuan 11
Taizhou 11
Lomé 10
Miami 10
North Bergen 10
Redwood City 10
Annandale 9
Boston 9
City of London 9
Fuzhou 9
Hangzhou 9
Jiaxing 9
Madrid 9
Willemstad 9
Cotonou 8
Da Nang 8
Manchester 8
McKinney 8
Naples 8
Totale 6.809
Salva come PNG Salva come JPEG
Nome #
A challenging case of abdominal pain associated to Helicobacter pylori infection 265
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 250
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 230
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 228
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 223
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 220
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 218
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 217
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 216
Identification of new BMP6 pro-peptide mutations in patients with iron overload 216
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 214
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 211
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 205
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 204
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 203
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 200
Altered paraoxonase expression in patients with genetic haemochromatosis. 197
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 193
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 190
Paraoxonase-1 status in patients with hereditary hemochromatosis 186
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 179
COBALAMIN DEFICIENCY IN THE ELDERLY 176
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 175
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 172
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 168
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 163
Modern iron replacement therapy: clinical and pathophysiological insights 163
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 163
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 162
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 162
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 160
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 160
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 158
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 157
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 154
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 153
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 149
Reduced serum hepcidin levels in patients with chronic hepatitis C 147
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 146
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 141
Iron replacement in inflammatory bowel disease: an evolving scenario 139
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation 135
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 132
Treatment options for anemia in the elderly 131
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 131
Iron metabolism in infections: Focus on COVID-19 131
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 130
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 127
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 126
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 124
Iron deficiency in the elderly population, revisited in the hepcidin era. 122
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 121
Hyperferritinemia and diagnosis of type 1 Gaucher disease 120
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 118
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 118
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 116
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 115
Paraoxonase-1 status in patients with hereditary hemochromatosis. 115
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 114
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 112
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 110
Impact of natural Neuromedin-B receptor variants on iron metabolism 106
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 103
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 100
Hemochromatosis classification: update and recommendations by the BIOIRON Society 99
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 97
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 96
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 91
Inflammation and iron homeostasis - what do blood tests mean? 89
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 85
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 84
ERFE regulation in sickle cell disease: complex but promising 83
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 75
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 72
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 63
Manipulating hepcidin in polycythemia vera 60
Recent Advancement of Hematology: Know, How to Do, Let Know 57
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 54
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry 41
Clinically recognized sepsis in older adults admitted to medical wards: patient characteristics and hospital outcomes from the REPOSI register 33
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 30
Red blood cell distribution width and blood transfusions are associated with 2-year mortality after transcatheter aortic valve implantation in males but not in females: sex-related differences in hematological predictors 21
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry 20
Prescription of SGLT-2 inhibitors alone or in combination with RAS-inhibitors in patients with diabetes mellitus and comorbid cardiovascular disease, chronic kidney disease or cardiorenal disease: a real-world evidence study from the REPOSI registry 19
Diagnostics: Markers of Body Iron Status 17
Diagnostics: Markers of Body Iron Status 15
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 13
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 12
null 1
Totale 11.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.719
article - articoli 30.996
book - libri 0
conference - conferenze 8.979
curatela - curatele 0
other - altro 571
patent - brevetti 0
selected - selezionate 0
volume - volumi 173
Totale 81.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022290 0 0 0 0 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20251.570 82 111 65 255 71 50 94 71 195 94 150 332
2025/20265.034 321 267 356 909 1.332 260 394 235 375 272 90 223
2026/20271.114 81 137 215 644 37 0 0 0 0 0 0 0
Totale 11.717